CVRx up on raising lower end of 2022 sales forecast range
** Medical device maker CVRx Inc's shares CVRX.O rise
12.7% to $8.51
** Co raises lower end of its 2022 sales forecast range to
$20.5 mln to $23 mln, vs prior outlook of between $20 mln and
$23 mln urn:newsml:reuters.com:*:nGNXbxCMkP
** Forecast raise follows a 90% increase in Q2 sales of its
heart failure device
** Including session gains, stock down ~30 YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Cvrx
See all newsBrief: Cvrx Appoints John Landry As Chief Financial Officer
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
CVRx, Inc. reports results for the quarter ended June 30 - Earnings Summary
CVRx Q2 revenue beats estimates, outlook cut on sales force, payer challenges
Brief: CVRx Q2 Revenue USD 15.705 Million Vs. IBES Estimate USD 15.5 Million